From: Predictors of total morbidity burden on days 3, 5 and 8 after cardiac surgery
Morbidity type | C-POMS criteria |
---|---|
Pulmonary | Presence of one or more of the following: ▪ New requirement for oxygen or respiratory support (including nebuliser therapy or request for chest physiotherapy on or after D5) ▪ Pleural effusion requiring drainage |
Infectious | Presence of one or more of the following: ▪ Currently on antibiotics ▪ Has had a temperature of >38 °C in the last 24 h ▪ Has a white cell count/CRP level requiring in-hospital review or treatment |
Renal | Presence of one or more of the following: ▪ Presence of decreased urine output requiring intervention (including IV furosemide) ▪ Increased serum creatinine (>30% from pre-operative level) ▪ Urinary catheter in situ ▪ New urinary incontinence ▪ Serum potassium abnormalities requiring treatment |
Gastrointestinal | Presence of one or more of the following: ▪ Unable to tolerate an enteral diet for any reason including nausea, vomiting and abdominal distension ▪ Nasogastric tube ▪ Diagnosis of a gastrointestinal bleed ▪ Diarrhoea |
Cardiovascular | Presence of one or more of the following: ▪ The use of inotropic therapy for any cardiovascular cause ▪ Pacing wires (on or after D5) and/or requiring temporary or new permanent pacing ▪ Diagnostic tests or therapy within the last 24 h for any of the following: (1) new MI or ischaemia, (2) hypotension (requiring fluid therapy, pharmacological therapy or omission of pharmacological therapy, (3) atrial or ventricular arrhythmias, (4) cardiogenic pulmonary oedema, thrombotic event (requiring anticoagulation), (5) hypertension (pharmacological therapy or omission of pharmacological therapy) |
Neurological | New neurological deficit (including confusion, delirium, coma, lack of coordination, drowsy/slow to wake, poor swallow, blurred vision, sedated, changing loss of consciousness) |
Haematological | Presence of one or more of the following: ▪ Untherapeutic INR requiring pharmacological therapy or omission of pharmacological therapy ▪ Requirement for any of the following within the last 24 h: packed erythrocytes, platelets, fresh-frozen plasma, or cryoprecipitate |
Wound | Presence of one or more of the following: ▪ Wound dehiscence requiring surgical exploration or drainage of pus from the operation wound with or without isolation of organisms ▪ Chest drains ▪ Wound pain significant enough to require continuing or escalating analgesic intervention |
Pain | Postoperative pain significant enough to require parenteral opioids and/or continuing or additional analgesia |
Endocrine | New or additional requirements for blood sugar management |
Electrolyte | Electrolyte (including sodium, urea, phosphate) imbalance requiring oral or intravenous intervention (not including potassium as included in renal category) |
Review | Remaining in hospital for further review, investigation and/or procedure |
Assisted ambulation | A new or escalated post-operative requirement for mobility assistance (including wheelchair, crutches, zimmer frame, walking sticks or assistance) |